EP 1178800 A1 20020213 - TREATMENT OF NEURODEGENERATIVE DISORDERS USING ASPARTYL PROTEASE INHIBITORS
Title (en)
TREATMENT OF NEURODEGENERATIVE DISORDERS USING ASPARTYL PROTEASE INHIBITORS
Title (de)
BEHANDLUNG VON NEURODEGENERATIVEN STÖRUNGEN UNTER VERWENDUNG DER INHIBITOREN VON ASPARTYL-PROTEASE
Title (fr)
TRAITEMENT DES MALADIES NEURODEGENERATIVES PAR DES INHIBITEURS DE L'ASPARTYL PROTEASE
Publication
Application
Priority
- US 0007804 W 20000324
- US 12595899 P 19990324
Abstract (en)
[origin: WO0056335A1] The present invention relates to (i) non-peptide aspartyl protease inhibitors; (ii) methods for modulating the processing of an amyloid precursor protein (APP); (iii) methods for modulating the processing of a tau protein ( tau -protein); and (iv) methods for treating neurodegenerative diseases.
IPC 1-7
IPC 8 full level
C07D 211/58 (2006.01); A61K 31/4035 (2006.01); A61K 31/445 (2006.01); A61K 31/4465 (2006.01); A61K 31/4468 (2006.01); A61K 31/4525 (2006.01); A61K 31/454 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 43/00 (2006.01); C07D 209/48 (2006.01); C07D 211/62 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP)
A61K 31/4035 (2013.01); A61K 31/445 (2013.01); A61K 31/4465 (2013.01); A61K 31/4525 (2013.01); A61K 31/454 (2013.01); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0056335 A1 20000928; AU 3771700 A 20001009; CA 2367112 A1 20000928; EP 1178800 A1 20020213; EP 1178800 A4 20020731; JP 2002539260 A 20021119
DOCDB simple family (application)
US 0007804 W 20000324; AU 3771700 A 20000324; CA 2367112 A 20000324; EP 00916643 A 20000324; JP 2000606240 A 20000324